Net revenues increased by 39% yoy to Rs15.4bn driven by robust volume growth in fertilisers (+40%) as well as healthy performance in chemical division. EBITDA increased by 100% yoy to Rs1.6bn and EBITDA margins expanded by 340 bps yoy to 10.5%. Chemical revenues stood at Rs4.7bn (+8% yoy) led by 7% yoy volume growth in caprolactam. Segment EBIT grew 3x yoy to Rs721mn driven by 42% yoy increase in caprolactam-benzene spread to US$1100/MT. EBIT margins improved 1,125bps to 15%. channel inventory remains low due to higher consumption and lower imports in 9MFY18. Caprolactam-benzene spreads are expected to remain at US$1000/MT in FY18....